Search research articles
Contact Us
Filters
Showing results (151-160 of 176) with videos related to
Page
of 18
Sort By:
Ebiomedicine
|
December 13, 2024
Safety and toxicity of Iopofosine I 131 (CLR 131) with external beam radiation therapy in recurrent or metastatic head and neck cancer: results of a phase 1 single-centre, open-label, single-arm, dose escalation and dose expansion study
Justine Yang Bruce, Adam Burr, Randall J Kimple, et al.
Hematological Oncology
|
August 4, 2021
Impact of initial chemotherapy regimen on outcomes for patients with double-expressor lymphoma: A multi-center analysis
Christopher R D'Angelo, Walter Hanel, Yi Chen, et al.
NPJ Genomic Medicine
|
September 22, 2021
Predicting cancer drug TARGETS - TreAtment Response Generalized Elastic-neT Signatures
Nicholas R Rydzewski, Erik Peterson, Joshua M Lang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2020
Randomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial Cancer
Matthew D Galsky, Amir Mortazavi, Matthew I Milowsky, et al.
American Journal of Medical Genetics. Part A
|
April 6, 2011
Multiple increased osteoclast functions in individuals with neurofibromatosis type 1
David A Stevenson, Jincheng Yan, Yongzheng He, et al.
Communications Biology
|
March 14, 2024
A platform-independent AI tumor lineage and site (ATLAS) classifier
Nicholas R Rydzewski, Yue Shi, Chenxuan Li, et al.
JAMA Oncology
|
September 23, 2021
Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate Cancer
Rahul Aggarwal, Nicholas R Rydzewski, Li Zhang, et al.
Journal of the National Cancer Institute
|
August 1, 2022
Surveillance Imaging vs Symptomatic Recurrence Detection and Survival in Stage II-III Breast Cancer (AFT-01)
Jessica R Schumacher, Heather B Neuman, Menggang Yu, et al.
The Lancet. Oncology
|
October 17, 2016
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis
Shuang G Zhao, S Laura Chang, Daniel E Spratt, et al.
European Urology
|
December 18, 2017
Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes
Matthew D Galsky, Huan Wang, Noah M Hahn, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 176) with videos related to
Sort By:
Page
of 18
Ebiomedicine
|
December 13, 2024
Safety and toxicity of Iopofosine I 131 (CLR 131) with external beam radiation therapy in recurrent or metastatic head and neck cancer: results of a phase 1 single-centre, open-label, single-arm, dose escalation and dose expansion study
Justine Yang Bruce, Adam Burr, Randall J Kimple, et al.
Hematological Oncology
|
August 4, 2021
Impact of initial chemotherapy regimen on outcomes for patients with double-expressor lymphoma: A multi-center analysis
Christopher R D'Angelo, Walter Hanel, Yi Chen, et al.
NPJ Genomic Medicine
|
September 22, 2021
Predicting cancer drug TARGETS - TreAtment Response Generalized Elastic-neT Signatures
Nicholas R Rydzewski, Erik Peterson, Joshua M Lang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2020
Randomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial Cancer
Matthew D Galsky, Amir Mortazavi, Matthew I Milowsky, et al.
American Journal of Medical Genetics. Part A
|
April 6, 2011
Multiple increased osteoclast functions in individuals with neurofibromatosis type 1
David A Stevenson, Jincheng Yan, Yongzheng He, et al.
Communications Biology
|
March 14, 2024
A platform-independent AI tumor lineage and site (ATLAS) classifier
Nicholas R Rydzewski, Yue Shi, Chenxuan Li, et al.
JAMA Oncology
|
September 23, 2021
Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate Cancer
Rahul Aggarwal, Nicholas R Rydzewski, Li Zhang, et al.
Journal of the National Cancer Institute
|
August 1, 2022
Surveillance Imaging vs Symptomatic Recurrence Detection and Survival in Stage II-III Breast Cancer (AFT-01)
Jessica R Schumacher, Heather B Neuman, Menggang Yu, et al.
The Lancet. Oncology
|
October 17, 2016
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis
Shuang G Zhao, S Laura Chang, Daniel E Spratt, et al.
European Urology
|
December 18, 2017
Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes
Matthew D Galsky, Huan Wang, Noah M Hahn, et al.
Page
of 18